605,648-share sale and 10b5-1 plan trades at Alignment Healthcare (ALHC)
Rhea-AI Filing Summary
Alignment Healthcare, Inc. reported proposed and recent sales of its common stock by a trust and an individual in a Form 144 disclosure. The filing lists multiple 10b5-1 plan sales including 180,000 shares on 03/10/2026, 180,000 on 02/10/2026, 180,000 on 01/12/2026, and a 605,648-share sale on 12/29/2025. It also shows 124,172 shares acquired from RSU vesting on 03/08/2022.
Positive
- None.
Negative
- None.
Insights
Form 144 lists multiple planned and completed sales under a 10b5-1 plan and an individual sale.
The filing shows recurring 10b5-1 plan sales by JEK Trust — three entries of 180,000 shares each on 01/12/2026, 02/10/2026, and 03/10/2026 — and a separate 605,648-share sale recorded on 12/29/2025. These are reported dispositions of Common Stock.
Cash‑flow treatment and buyer identities are not stated in the excerpt; timing and pattern suggest systematic plan activity. Subsequent filings or broker statements would show net proceeds and any remaining plan limits.
Transactions are reported under Rule 144 and reference a 10b5-1 sales plan and RSU vesting.
The disclosure cites an RSU vesting event of 124,172 shares on 03/08/2022 and identifies a 10b5-1 Sales Plan for JEK Trust dated 02/08/2021. The filing lists the Nasdaq as the market for the securities.
Relevant qualifiers (plan name, trust document date) are included verbatim. Any regulatory compliance implications depend on trade execution details and are not specified in the provided excerpt.